168 related articles for article (PubMed ID: 35277532)
41. The neutrophil to albumin ratio as a predictor of pathological complete response in rectal cancer patients following neoadjuvant chemoradiation.
Tawfik B; Mokdad AA; Patel PM; Li HC; Huerta S
Anticancer Drugs; 2016 Oct; 27(9):879-83. PubMed ID: 27434664
[TBL] [Abstract][Full Text] [Related]
42. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy.
Karaca M; Salim E; Alemdar MS; Deniz Karaca Ö; Arıcı MÖ
Med Sci Monit; 2024 Mar; 30():e943750. PubMed ID: 38544312
[TBL] [Abstract][Full Text] [Related]
43. Combination of Preoperative Plasma Fibrinogen and Neutrophil-to-Lymphocyte Ratio (the F-NLR Score) as a Prognostic Marker of Locally Advanced Rectal Cancer Following Preoperative Chemoradiotherapy.
Sun Y; Zhang Y; Huang Z; Lin H; Lu X; Huang Y; Chi P
World J Surg; 2020 Jun; 44(6):1975-1984. PubMed ID: 32020327
[TBL] [Abstract][Full Text] [Related]
44. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z
Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933
[TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model.
Sun Y; Zhang Y; Wu X; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X; Chi P
J Surg Oncol; 2018 Mar; 117(4):737-744. PubMed ID: 29228455
[TBL] [Abstract][Full Text] [Related]
46. Predictive Value of Leukocyte- and Platelet-Derived Ratios in Rectal Adenocarcinoma.
Ward WH; Goel N; Ruth KJ; Esposito AC; Lambreton F; Sigurdson ER; Meyer JE; Farma JM
J Surg Res; 2018 Dec; 232():275-282. PubMed ID: 30463730
[TBL] [Abstract][Full Text] [Related]
47. Tumor Budding as a Prognostic Marker in Rectal Cancer Patients on Propensity Score Analysis.
Shin JK; Park YA; Huh JW; Yun SH; Kim HC; Lee WY; Kim SH; Ha SY; Cho YB
Ann Surg Oncol; 2021 Dec; 28(13):8813-8822. PubMed ID: 34232421
[TBL] [Abstract][Full Text] [Related]
48. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
49. Pretreatment blood biomarkers combined with magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Shi X; Zhao M; Shi B; Chen G; Yao H; Chen J; Wan D; Gu W; He S
Front Oncol; 2022; 12():916840. PubMed ID: 36016621
[TBL] [Abstract][Full Text] [Related]
50. The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Cui J; Yang L; Guo L; Shao Y; Tan D; Li N; Zhang H
Oncotarget; 2017 Jun; 8(23):37845-37854. PubMed ID: 28103579
[TBL] [Abstract][Full Text] [Related]
51. Lateral lymph node dissection reduces local recurrence of locally advanced lower rectal cancer in the absence of preoperative neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
Gao X; Wang C; Yu Y; Singh D; Yang L; Zhou Z
World J Surg Oncol; 2020 Nov; 18(1):304. PubMed ID: 33228677
[TBL] [Abstract][Full Text] [Related]
52. Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer.
Jiang DM; Raissouni S; Mercer J; Kumar A; Goodwin R; Heng DY; Tang PA; Doll C; MacLean A; Powell E; Price-Hiller J; Monzon J; Cheung WY; Vickers MM
Ann Oncol; 2015 Oct; 26(10):2102-6. PubMed ID: 26232491
[TBL] [Abstract][Full Text] [Related]
53. Significance of ypTNM stage in determining the prognosis and therapy after surgery for locally advanced rectal cancer.
Chen Y; Sun J; Dong X; Sun D; Qu Y
World J Surg Oncol; 2023 Jun; 21(1):174. PubMed ID: 37287039
[TBL] [Abstract][Full Text] [Related]
54. Does Neutrophil-to-Lymphocyte Ratio (NLR) Predict Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma?
Anand S; Bhati G; Gurram R; Gnanasekaran S; Kate V; Pottakkat B; Kalayarasan R
J Gastrointest Cancer; 2021 Jun; 52(2):659-665. PubMed ID: 32607960
[TBL] [Abstract][Full Text] [Related]
55. C-Reactive Protein as Predictive Biomarker for Response to Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Retrospective Study.
Aires F; Rodrigues D; Lamas MP; Herdeiro MT; Figueiras A; Oliveira MJ; Marques M; Pinto AT
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158759
[TBL] [Abstract][Full Text] [Related]
56. Neoadjuvant Chemoradiotherapy and Tumor Recurrence in Patients with Early T-Stage Cancer of the Lower Rectum.
Hayes IP; Milanzi E; Gibbs P; Reece JC
Ann Surg Oncol; 2020 May; 27(5):1570-1579. PubMed ID: 31773520
[TBL] [Abstract][Full Text] [Related]
57. Prognostic Impact of Perineural Invasion in Rectal Cancer After Neoadjuvant Chemoradiotherapy.
Kim CH; Yeom SS; Lee SY; Kim HR; Kim YJ; Lee KH; Lee JH
World J Surg; 2019 Jan; 43(1):260-272. PubMed ID: 30151676
[TBL] [Abstract][Full Text] [Related]
58. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1-2 rectal cancer.
Xia LJ; Li W; Zhai JC; Yan CW; Chen JB; Yang H
BMC Cancer; 2020 Mar; 20(1):208. PubMed ID: 32164623
[TBL] [Abstract][Full Text] [Related]
59. Identification of proteins associated with treatment response of neoadjuvant chemoradiotherapy in rectal mucinous adenocarcinoma by co-expression network analysis based on proteomic analysis.
Sun Y; Lin Y; Deng Y; Wu X; Zhong J; Huang Y; Jiang W; Chi P
J Proteomics; 2022 Mar; 254():104472. PubMed ID: 34990823
[TBL] [Abstract][Full Text] [Related]
60. Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy.
Koo T; Song C; Kim JS; Kim K; Chie EK; Kang SB; Lee KW; Kim JH; Jeong SY; Kim TY
PLoS One; 2015; 10(9):e0138728. PubMed ID: 26381522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
